Six month trading update
The Probiotic To Support Heart Health
ProBiotix Health is a life sciences company that develops probiotic formulations to support cardiometabolic health
Since its creation, ProBiotix has become a global leader in microbiome modulating
probiotics for use in food supplements and nutraceuticals
At the heart of the Company’s mission lies a unique approach; discovering groundbreaking probiotics, ensuring their benefits through solid science, and bringing to market effective finished probiotic-based products for human health across the globe.
![identification_icon](/images/probiotixhealthlibraries/default-album/assets/identification_icon.png)
Identification
Identification and evolution of ground breaking probiotic strains targeting lifestyle conditions that are prevalent in healthy ageing.
![validation_icon](/images/probiotixhealthlibraries/default-album/assets/validation_icon.png)
Validation
Scientific validation ensures the probiotic strains stand on a solid foundation of validated safety and efficacy for human health.
![commericalisation_icon](/images/probiotixhealthlibraries/default-album/assets/commericalisation_icon.png)
Commercialisation
Developing advanced probiotic-based product formulations targeted for cardiometabolic health, ensuring measurable health benefits. Providing business-to-business turn-key or “white label”, probiotic based supplements to organisations worldwide.
![probiotix-product-logo-lpldl](/images/probiotixhealthlibraries/default-album/assets/probiotix-product-logo-lpldl.png)
LP LDL
Superior Probiotic Strain for Cardiometabolic Health
Independent clinical studies¹ have shown that ProBiotix’s principal identified probiotic strain, LPLDL®, can reduce key cardiovascular risk biomarkers, such as total cholesterol by 36%, LDL by 28%, non-HDL cholesterol by 17% and apolipoprotein B by 28%.
Latest RNS News
Latest Interview
Aquis-listed ProBiotix Health taps into demand for cardiovascular disease treatments
Stephen O'Hara | 23 February 2023
IG UK | Youtube